Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Clinical Therapeutics|August 19, 2007
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemiaMaria Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, et al.
Molecular Genetics & Genomic Medicine|April 2, 2014
High frequency of exon 15 deletion in the FANCA gene in Tunisian patients affected with Fanconi anemia disease: implication for diagnosisAhlem Amouri, Faten Talmoudi, Olfa Messaoud, et al.
The Lancet. Haematology|May 30, 2020
Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trialAurelio Maggio, Antonis Kattamis, Mariagrazia Felisi, et al.
Blood|December 15, 2005
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemiaMaria Domenica Cappellini, Alan Cohen, Antonio Piga, et al.
Journal of Clinical Immunology|March 3, 2016
X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK MutationsZahra Aadam, Nadia Kechout, Abdelhamid Barakat, et al.
Journal of Clinical Immunology|October 15, 2015
Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988-2012)Fethi Mellouli, Imen Ben Mustapha, Monia Ben Khaled, et al.
The Journal of Experimental Medicine|July 5, 2006
X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 productionOrchidée Filipe-Santos, Jacinta Bustamante, Margje H Haverkamp, et al.
The New England Journal of Medicine|March 27, 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaM Domenica Cappellini, Vip Viprakasit, Ali T Taher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2013
Clinical features of Candidiasis in patients with inherited interleukin 12 receptor β1 deficiencyMonia Ouederni, Ozden Sanal, Aydan Ikinciogullari, et al.
The Journal of Allergy and Clinical Immunology|April 5, 2014
Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levelsAtfa Sassi, Sandra Lazaroski, Gang Wu, et al.
Pageof 11